Copyright Reports & Markets. All rights reserved.

Global Radiation Injury Drugs Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Radiation Injury Drugs Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Radiation Injury Drugs Market Size Growth Rate by Product
      • 1.4.2 Aerosurf
      • 1.4.3 BMX-001
      • 1.4.4 C-2E2
      • 1.4.5 C-2E5
      • 1.4.6 Des-Asp Angiotensin 1
      • 1.4.7 DG-3
      • 1.4.8 Others
    • 1.5 Market by End User
      • 1.5.1 Global Radiation Injury Drugs Market Size Growth Rate by End User
      • 1.5.2 ASCs
      • 1.5.3 Hospital
      • 1.5.4 Clinic
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Radiation Injury Drugs Market Size
      • 2.1.1 Global Radiation Injury Drugs Revenue 2014-2025
      • 2.1.2 Global Radiation Injury Drugs Sales 2014-2025
    • 2.2 Radiation Injury Drugs Growth Rate by Regions
      • 2.2.1 Global Radiation Injury Drugs Sales by Regions
      • 2.2.2 Global Radiation Injury Drugs Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Radiation Injury Drugs Sales by Manufacturers
      • 3.1.1 Radiation Injury Drugs Sales by Manufacturers
      • 3.1.2 Radiation Injury Drugs Sales Market Share by Manufacturers
      • 3.1.3 Global Radiation Injury Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Radiation Injury Drugs Revenue by Manufacturers
      • 3.2.1 Radiation Injury Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Radiation Injury Drugs Revenue Share by Manufacturers (2014-2019)
    • 3.3 Radiation Injury Drugs Price by Manufacturers
    • 3.4 Radiation Injury Drugs Manufacturing Base Distribution, Product Types
      • 3.4.1 Radiation Injury Drugs Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Radiation Injury Drugs Product Type
      • 3.4.3 Date of International Manufacturers Enter into Radiation Injury Drugs Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Radiation Injury Drugs Sales by Product
    • 4.2 Global Radiation Injury Drugs Revenue by Product
    • 4.3 Radiation Injury Drugs Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Radiation Injury Drugs Breakdown Data by End User

    6 North America

    • 6.1 North America Radiation Injury Drugs by Countries
      • 6.1.1 North America Radiation Injury Drugs Sales by Countries
      • 6.1.2 North America Radiation Injury Drugs Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Radiation Injury Drugs by Product
    • 6.3 North America Radiation Injury Drugs by End User

    7 Europe

    • 7.1 Europe Radiation Injury Drugs by Countries
      • 7.1.1 Europe Radiation Injury Drugs Sales by Countries
      • 7.1.2 Europe Radiation Injury Drugs Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Radiation Injury Drugs by Product
    • 7.3 Europe Radiation Injury Drugs by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Radiation Injury Drugs by Countries
      • 8.1.1 Asia Pacific Radiation Injury Drugs Sales by Countries
      • 8.1.2 Asia Pacific Radiation Injury Drugs Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Radiation Injury Drugs by Product
    • 8.3 Asia Pacific Radiation Injury Drugs by End User

    9 Central & South America

    • 9.1 Central & South America Radiation Injury Drugs by Countries
      • 9.1.1 Central & South America Radiation Injury Drugs Sales by Countries
      • 9.1.2 Central & South America Radiation Injury Drugs Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Radiation Injury Drugs by Product
    • 9.3 Central & South America Radiation Injury Drugs by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Radiation Injury Drugs by Countries
      • 10.1.1 Middle East and Africa Radiation Injury Drugs Sales by Countries
      • 10.1.2 Middle East and Africa Radiation Injury Drugs Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Radiation Injury Drugs by Product
    • 10.3 Middle East and Africa Radiation Injury Drugs by End User

    11 Company Profiles

    • 11.1 FirstString Research Inc
      • 11.1.1 FirstString Research Inc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 FirstString Research Inc Radiation Injury Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 FirstString Research Inc Radiation Injury Drugs Products Offered
      • 11.1.5 FirstString Research Inc Recent Development
    • 11.2 PharmaIN Corp
      • 11.2.1 PharmaIN Corp Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 PharmaIN Corp Radiation Injury Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 PharmaIN Corp Radiation Injury Drugs Products Offered
      • 11.2.5 PharmaIN Corp Recent Development
    • 11.3 Synedgen Inc
      • 11.3.1 Synedgen Inc Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Synedgen Inc Radiation Injury Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Synedgen Inc Radiation Injury Drugs Products Offered
      • 11.3.5 Synedgen Inc Recent Development
    • 11.4 Tonix Pharmaceuticals Holding Corp
      • 11.4.1 Tonix Pharmaceuticals Holding Corp Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Products Offered
      • 11.4.5 Tonix Pharmaceuticals Holding Corp Recent Development
    • 11.5 Windtree Therapeutics Inc
      • 11.5.1 Windtree Therapeutics Inc Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Windtree Therapeutics Inc Radiation Injury Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Windtree Therapeutics Inc Radiation Injury Drugs Products Offered
      • 11.5.5 Windtree Therapeutics Inc Recent Development

    12 Future Forecast

    • 12.1 Radiation Injury Drugs Market Forecast by Regions
      • 12.1.1 Global Radiation Injury Drugs Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Radiation Injury Drugs Revenue Forecast by Regions 2019-2025
    • 12.2 Radiation Injury Drugs Market Forecast by Product
      • 12.2.1 Global Radiation Injury Drugs Sales Forecast by Product 2019-2025
      • 12.2.2 Global Radiation Injury Drugs Revenue Forecast by Product 2019-2025
    • 12.3 Radiation Injury Drugs Market Forecast by End User
    • 12.4 North America Radiation Injury Drugs Forecast
    • 12.5 Europe Radiation Injury Drugs Forecast
    • 12.6 Asia Pacific Radiation Injury Drugs Forecast
    • 12.7 Central & South America Radiation Injury Drugs Forecast
    • 12.8 Middle East and Africa Radiation Injury Drugs Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Radiation Injury Drugs Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Radiation Injury Drugs market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Radiation Injury Drugs market based on company, product type, end user and key regions.

      This report studies the global market size of Radiation Injury Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Radiation Injury Drugs in these regions.
      This research report categorizes the global Radiation Injury Drugs market by top players/brands, region, type and end user. This report also studies the global Radiation Injury Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      FirstString Research Inc
      PharmaIN Corp
      Synedgen Inc
      Tonix Pharmaceuticals Holding Corp
      Windtree Therapeutics Inc

      Market size by Product
      Aerosurf
      BMX-001
      C-2E2
      C-2E5
      Des-Asp Angiotensin 1
      DG-3
      Others
      Market size by End User
      ASCs
      Hospital
      Clinic
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Radiation Injury Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Radiation Injury Drugs market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Radiation Injury Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Radiation Injury Drugs submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Radiation Injury Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Radiation Injury Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now